| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/05/2012 | WO2010139180A8 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 01/05/2012 | US20120004311 Optically pure apogossypol derivative as pan-active inhibitor of anti-apoptotic b-cell lymphoma/leukemia-2 (bcl-2) |
| 01/05/2012 | US20120004310 Non-peptide bdnf neurotrophin mimetics |
| 01/05/2012 | US20120004306 External preparation containing analgesic/anti-inflammatory agent |
| 01/05/2012 | US20120004305 External preparation containing analgesic/anti-inflammatory agent |
| 01/05/2012 | US20120004298 Ophthalmic devices containing chemokine antagonists |
| 01/05/2012 | US20120004292 Composition for injection comprising an injection medicinal product and a gel |
| 01/05/2012 | US20120004280 RNA Interference Mediated Inhibition of the High Affinity 1 gE Receptor Alpha Chain (FC Epsilon R1 Alpha) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/05/2012 | US20120004275 Sceletium extract and uses thereof |
| 01/05/2012 | US20120004267 Apoptosis signal-regulating kinase inhibitors |
| 01/05/2012 | US20120004263 Compounds for the treatment of pathologies associated with aging and degenerative disorders |
| 01/05/2012 | US20120004261 Mif modulators |
| 01/05/2012 | US20120004259 Method of treatment or prophylaxis |
| 01/05/2012 | US20120004253 Novel Fused Pyrrolocarbazoles |
| 01/05/2012 | US20120004252 New ccr2 receptor antagonists and uses thereof |
| 01/05/2012 | US20120004250 Pyrimidine classical cannabinoid compounds and related methods of use |
| 01/05/2012 | US20120004248 Methods of using a methylxanthine compound |
| 01/05/2012 | US20120004247 Organic compounds |
| 01/05/2012 | US20120004244 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004237 Salt of cd 80 antagonist |
| 01/05/2012 | US20120004233 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 01/05/2012 | US20120004228 Bis Aromatic Compounds for Use as LTC4 Synthase Inhibitors |
| 01/05/2012 | US20120004226 Modulators of Muscarinic Receptors |
| 01/05/2012 | US20120004222 Cb2 receptor ligands for the treatment of pain |
| 01/05/2012 | US20120004217 Therapeutic agents useful for treating pain |
| 01/05/2012 | US20120004215 N-oxides of diazabicyclononyl pyrimidine derivatives and their medical use |
| 01/05/2012 | US20120004214 N-oxides of 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivatives useful as nicotinic acetylcholine receptor ligands |
| 01/05/2012 | US20120004212 Organic compounds |
| 01/05/2012 | US20120004211 1,2,4-triazole derivatives as sigma receptor inhibitors |
| 01/05/2012 | US20120004210 Substituted quinazoline compounds |
| 01/05/2012 | US20120004207 Therapeutic uses of derivatives of piperidinyl-and piperidinyl-alkyl carbamates |
| 01/05/2012 | US20120004205 Il-13 induced gene signature for eosinophilic esophagitis |
| 01/05/2012 | US20120004202 Medicaments for the treatment or prevention of fibrotic diseases |
| 01/05/2012 | US20120004201 Phosphodiestarase inhibitors |
| 01/05/2012 | US20120004199 Scaffolds |
| 01/05/2012 | US20120004190 Heterobifunctional pan-selectin inhibitors |
| 01/05/2012 | US20120004184 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 01/05/2012 | US20120004175 Inhibitors of nf-kb activity |
| 01/05/2012 | US20120003320 Particles which are surface coated with hyaluronan or one of the derivatives thereof and the use of same as biological vectors for active substances |
| 01/05/2012 | US20120003300 Composition Comprising Vascular Endothelial Growth Factor (VEGF) for the Treatment of Hair Loss |
| 01/05/2012 | US20120003292 Anti-inflammatory dissolvable film |
| 01/05/2012 | US20120003285 Method for manufacturing capsule series, and related capsule series |
| 01/05/2012 | US20120003282 Pharmaceutical compositions of dextran polymer derivatives |
| 01/05/2012 | US20120003267 Therapeutic Agents |
| 01/05/2012 | US20120003266 Virus like particle compositions and methods of use |
| 01/05/2012 | US20120003252 Isoforms of human somatostatin receptor type 5 produced by alternative processing and oligo-nucleotide pairs for detection thereof by pcr |
| 01/05/2012 | US20120003237 Wise binding agents and epitopes |
| 01/05/2012 | US20120003235 Anti-lymphotoxin antibodies |
| 01/05/2012 | US20120003231 Cell surface molecule mediating cell adhesion and signal transmission |
| 01/05/2012 | US20120003229 Modulators of cytokine mediated signalling pathways and integrin alphavbeta3 receptor antagonists for combination therapy |
| 01/05/2012 | US20120003228 Methods for predicting autoimmune disease risk |
| 01/05/2012 | US20120003224 ANGIOGENIC AND IMMUNOLOGIC APPLICATIONS OF ANTI-CD160 SPECIFIC COMPOUNDS OBTAINABLE FROM mAb CL1-R2 |
| 01/05/2012 | US20120003213 Methods Of Enhancing Antibody-Dependent Cellular Cytotoxicity |
| 01/05/2012 | US20120003203 Compositions and Methods for Treating S. Pneumoniae Infection |
| 01/05/2012 | US20120003188 Compositions and Methods of Using Living and Non-Living Bioactive Devices with Components Derived from Self-Renewing Colony Forming Cells Cultured and Expanded In Vitro |
| 01/05/2012 | US20120003184 Sodium salt of 5-cyclopropyl-2-benzoic acid as dhodh inhibitor |
| 01/05/2012 | US20120003183 Addition salts of tromethamine with azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 01/05/2012 | US20120003155 Dendrimer based nanodevices for therapeutic and imaging purposes |
| 01/05/2012 | US20120003153 Novel indolyl-oxadiazolyl-diazabicyclononane derivatives and their medical and diagnostical use |
| 01/05/2012 | DE102010026090A1 Preparing a matrix for a sublingual dosage form, preferably a tablet, comprises preparing a mixture of gum arabic and active ingredients, and extruding the obtained mixture |
| 01/05/2012 | CA2804225A1 Heterocyclic compound and p27kip1 degradation inhibitor |
| 01/05/2012 | CA2804194A1 Compounds act at multiple prostaglandin receptors giving a general anti-inflammatory response |
| 01/05/2012 | CA2803842A1 Novel nicotinamide derivative or salt thereof |
| 01/05/2012 | CA2803624A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803620A1 Heterocyclic compounds and their uses |
| 01/05/2012 | CA2803558A1 .omega.3 fatty acid compound preparation |
| 01/05/2012 | CA2803358A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2803259A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 01/05/2012 | CA2802743A1 Apoptosis signal-regulating kinase inhibitors |
| 01/04/2012 | EP2402372A2 Therapeutic agent |
| 01/04/2012 | EP2402326A1 Crystals of hydrochloride salts of a Phenylalanine Derivative, Production Method Thereof and Use Thereof as alpha4 integrin Inhibitors |
| 01/04/2012 | EP2402316A1 Piperidine derivatives |
| 01/04/2012 | EP2402310A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402309A1 CCR9 inhibitors and methods of use thereof |
| 01/04/2012 | EP2402305A1 Loxoprofen derivative and pharmaceutical containing same |
| 01/04/2012 | EP2402020A1 Pharmaceutical composition comprising extracts of Bupleurum with immunomodulating function |
| 01/04/2012 | EP2402013A1 Methods of Treating Chronic Inflammatory Diseases using a GM-CSF Antagonist |
| 01/04/2012 | EP2401274A1 Imidazo [1, 2 -a]pyridines as jnk modulators |
| 01/04/2012 | EP2401273A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/04/2012 | EP2401270A1 Pyrazole derivatives used as ccr4 receptor antagonists |
| 01/04/2012 | EP2400971A1 Treatment of immunosuppression-related disorders |
| 01/04/2012 | EP2400962A1 Drug combinations containing pde4 inhibitors and nsaids |
| 01/04/2012 | EP2400961A1 Drug combinations containing pde4 inhibitors and nsaids |
| 01/04/2012 | EP2297148B1 Novel derivatives of (bridged piperazinyl)-1-alcanone and use thereof as p75 inhibitors |
| 01/04/2012 | EP2049502B1 2,4-substituted quinazolines as lipid kinase inhibitors |
| 01/04/2012 | EP1877366B1 Hydroxamic acid dervicatives as inhibitors of hdac enzymatic activity |
| 01/04/2012 | EP1422225B1 Benzoisoselenazole derivatives with anti-inflammation, antineoplastic and anti-thrombosis activity and their use |
| 01/04/2012 | EP1339663B1 Naphthalene derivatives |
| 01/04/2012 | CN1558765B Enantiomerically pure opioid diarylmethylpiperzine and methods of using same |
| 01/04/2012 | CN102307896A Fibronectin type III domain based scaffold compositions, methods and uses |
| 01/04/2012 | CN102307877A Dihydroetorphines and their preparation |
| 01/04/2012 | CN102307876A Synthesis of morphine-6-glucuronide or one of the derivatives thereof |
| 01/04/2012 | CN102307852A Cyclic amine compounds |
| 01/04/2012 | CN102307847A Indanyl compounds |
| 01/04/2012 | CN102307842A Plant extracts from acronychia species and their use |
| 01/04/2012 | CN102307578A Methods and compositions for treating inflammation and inflammation-related pathologies |
| 01/04/2012 | CN102304456A Health care medicinal wine |
| 01/04/2012 | CN102304171A Three alpha-conus polypeptides and use thereof |
| 01/04/2012 | CN102304156A Phenylethanoid glycoside components, and preparation method and application thereof |
| 01/04/2012 | CN102304124A Novel 1-2-dihydroquinoline derivative having glucocorticoid receptor binding activity |